Announcing NORD's new CEO

May 8, 2024

After 16 years serving as the President & CEO of the National Organization for Rare Disorders (NORD), and successor to NORD’s founder Abbey Meyers, Peter L. Saltonstall announces his retirement as NORD’s CEO. Pamela Gavin will take over as his successor effective May 1st. Pam has been an integral part of NORD’s success and evolution for the past 12 years leading many of NORD’s groundbreaking initiatives, including the creation and evolution of NORD’s IAMRARE® patient registry program, which boasts 50+ patient registries and 18,000+ enrolled participants. <You can read NORD’s full announcement of their new CEO Pamela Gavin on their website.> link to

Categories: Announcements


Media Contacts

Dawn Tucker
College of Pharmacy
Eileen Omizo-Whittenberg
College of Pharmacy